EVH Earnings Date: Nov 5, 2026 (Estimated) — Evolent Health, Inc.
NYSE · Healthcare · Health Information Services
Updated
When is EVH's next earnings date?
Evolent Health, Inc. (EVH) is expected to report Q3 2026 earnings on Thursday, November 5, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $0.06 on revenue of $727.1M.
How did EVH do in its last earnings report?
In its most recent report on Aug 6, 2026 (Q2 2026), Evolent Health, Inc. posted EPS of $0.02 versus the -$0.01 estimate, a beat of 166.7%. Revenue was $652.5M against a $597.7M estimate. The stock's 1-day post-earnings move was +16.6%.
How much does EVH stock move after earnings?
EVH beat EPS estimates in 5 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 19.7% (up or down) in the day after earnings.
About Evolent Health, Inc.
Evolent Health, Inc., a prominent healthcare firm, operates through its subsidiary, Evolent Health LLC, to furnish clinical and administrative solutions to both healthcare payers and providers across the United States. Its operations are divided into two principal segments: Evolent Health Services and Clinical Solutions. The Evolent Health Services division delivers an integrated platform encompassing both administrative and clinical functions, specifically designed for health plan management and the oversight of population health. This includes essential financial and administrative support, such as managing health plan operations, risk assessment, robust analytics and reporting, and strategic leadership. A cornerstone of this segment is "Identifi," its proprietary technology, which intelligently aggregates and analyzes data, streamlines care workflows, and actively engages patients, all with the aim of achieving patient-centered and cost-effective population health outcomes. Conversely, the Clinical Solutions segment specializes in offering sophisticated care management services for various stakeholders involved in specialty care delivery. These services are crucial for organizations transitioning from traditional fee-for-service models to value-based care, accommodating their unique stage of development and prevailing market dynamics, particularly in the fields of oncology and cardiology. The overarching objective of this segment is a holistic improvement in the total cost of care. Founded in 2011, Evolent Health, Inc. maintains its corporate headquarters in Arlington, Virginia.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-06 | Q2 2026 | -0.01 | 0.02 | +166.67% | $652.5M | ✅ Beat | +16.56% | +35.39% | +38.31% |
| 2026-05-07 | Q1 2026 | -0.07 | -0.02 | +71.43% | $496.2M | ✅ Beat | +11.49% | +7.83% | +10.18% |
| 2026-02-24 | Q4 2025 | 0.02 | 0.08 | +300.00% | $468.7M | ✅ Beat | +22.66% | +37.11% | -11.33% |
| 2025-11-06 | Q3 2025 | 0.11 | 0.05 | -54.55% | $479.5M | ❌ Miss | -17.33% | -30.67% | -34.50% |
| 2025-02-20 | Q4 2024 | 0.01 | -0.02 | -300.00% | $646.5M | ❌ Miss | -2.61% | -18.95% | -10.55% |
| 2024-11-07 | Q3 2024 | 0.34 | 0.04 | -88.24% | $621.4M | ❌ Miss | -45.62% | -48.43% | -54.95% |
| 2024-08-08 | Q2 2024 | 0.26 | 0.30 | +15.38% | $647.1M | ✅ Beat | +26.50% | +30.28% | +44.99% |
| 2024-02-22 | Q4 2023 | 0.15 | 0.23 | +53.33% | $556.1M | ✅ Beat | +14.44% | +13.91% | +8.90% |
Showing last 8 quarters.